Recruiting

Vitamin D

Sponsor:

Children's Hospital of Orange County

Code:

NCT07938333

Conditions

Acute Lymphoblastic Leukemia ALL

Eligibility Criteria

Sex: All

Age: 0 - 18

Healthy Volunteers: Not accepted

Study Details

Brief summary:

Brief Summary The purpose of this observational study is to better understand how vitamin D levels affect the gut microbiome (the bacteria that live in the intestines) in children who are newly diagnosed with acute lymphoblastic leukemia (ALL). Researchers want to learn whether low vitamin D levels are linked to changes in gut bacteria and whether this may affect how children with ALL respond to chemotherapy.

The main questions this study aims to answer are:

  • Are the gut bacteria different in children with ALL who have low vitamin D levels compared to those with normal vitamin D levels at the time of diagnosis?
  • How do vitamin D levels relate to changes in gut bacteria and related body processes before and after induction chemotherapy? Researchers will compare children who have low vitamin D levels with those who have normal vitamin D levels to see if there are differences in their gut bacteria and how those bacteria change during early treatment. The stool samples will be studied in specialized laboratories to better understand how vitamin D and gut bacteria interact.

The results of this study may help doctors understand whether monitoring and managing vitamin D levels could improve care and treatment outcomes for children with ALL.

Participants will:

Have four study visits:

  • Screening: Review and sign consent/assent forms, review of Inclusion/Exclusion Criteria, medical history, and current medications
  • At diagnosis (baseline): Review of medications, laboratory results, Vitamin D level, Fecal Sample Collection
  • Day 29-32 - At the end of induction chemotherapy: Review of medications, laboratory results, Vitamin D level, Fecal Sample Collection and Adverse event assessment
  • Day 90-97 after Induction: Review of medications, laboratory results, Vitamin D level, Fecal Sample Collection and Adverse event assessment

Conditions

Acute Lymphoblastic Leukemia ALL

Study ID

NCT07938333

Start date

Nov 9, 2026

Status verified date

Mar, 2026

Completion date

Dec 31, 2027

Anticipated

Primary completion date

Aug 31, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0 - 18

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Ages 0-18 years
  • Newly diagnosed with acute lymphoblastic leukemia, including B-cell ALL, T-cell ALL, mixed phenotype actue leukemia (MPAL), and Philadelphia-positive or Philadelphia-like ALL.

Exclusion Criteria:

  • Diagnosed with other malignancies, congenital gastrointestinal or bowel diseases, or inflammatory bowel diseases.
  • Hypersensitivity to vitamin D.
  • Pregnant.

Study Design

Enrollment

30 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Gut microbiome diversity [ Time Frame: Through study completion, up to 97 days ]

Central Contacts and Locations

Central contacts

Sun Yang, B.Pharm., Ph.D, R.Ph, BCPPS

(714) 516-5418syang@chapman.edu

Kathryn Duvall, MSN, RN, CCRP, CPON

(714) 509-8646kduvall@choc.org

Locations

Children's Hospital of Orange County

Recruiting

Orange, California, United States, 92868

Contacts

Kathryn Duvall, MSN RN CCRP CPON

7145098646kduvall@choc.org

More Information

Sponsor

Children's Hospital of Orange County

Last update posted

Nov 16, 2026

Last verified

Mar, 2026

Keywords

  • acute lymphoblastic leukemia
  • vitamin D
  • microbiome

Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-17. This information was provided to ClinicalTrials.gov by Children's Hospital of Orange County on 2026-11-16. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.